David Clair | Senior Director, IR and Corporate Development |
Charles Kummeth | President and CEO |
Jim Hippel | CFO |
Puneet Souda | SVB Leerink |
Catherine Schulte | Robert W. Baird |
Alex Nowak | Craig-Hallum Capital |
Dan Arias | Stifel |
Jacob Johnson | Stephens Inc |
Patrick Donnelly | Citigroup |
Good morning and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2021. At this time, all participants have been placed in a listen-only mode. And the call will be open for questions following management’s prepared remarks.
During our Q&A session, please limit yourself to one question and a follow-up. I would now like to turn the call over to David Clair, Bio-Techne's Senior Director, Investor Relations and Corporate Development.